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Introduction
1 The  N-acetyltransferase  2  (NAT2)  gene  plays  a  crucial  role  in  the  metabolism  of
xenobiotics, including many clinically useful drugs and exogenous chemicals present in
the diet, cigarette smoke and the environment (Hein 2002). Extensive polymorphism in
NAT2  gives  rise  to  a  wide  interindividual  variation  in  N-acetylation  capacity.  In
particular, a clear bimodal distribution is observed that segregates the rapid acetylator
phenotype, associated with a normal acetylation capacity, from the slow acetylator one,
characterized by a reduced enzyme activity. These two main metabolic phenotypes occur
with varying prevalence in populations of different ethnic origin (Upton et al. 2001).
2 The clinical consequences of the acetylation polymorphism can be severe if standard drug
doses are applied, exposing patients to an increased risk of adverse drug reactions or a
lack of therapeutic efficacy (Meisel 2002). In addition, in the last decades, an increasing
number of epidemiological studies have attempted to relate acetylation phenotype to a
variety of complex human disorders, such as bladder cancer, atopic diseases, diabetes,
Parkinson’s disease and many others (see Butcher et al. (2002) for a review). However, up
to now, association studies in NAT2 have led to conflicting results among (and even
within) human populations and most association findings have been difficult to replicate.
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One reason for these inconsistencies may relate to the fact that almost all studies focused
on a limited number of candidate polymorphisms, which were not necessarily the same
from one study to another (Goldstein 2003; Goldstein et al. 2003). A shift toward a gene-
based approach in which all  common variation within a gene is considered jointly is
advocated  for  future  association  studies  (Neale,  Sham 2004).  By  capturing  all  of  the
potential risk-conferring variations within NAT2, this approach should resolve much of
the controversial issues of candidate-polymorphism studies.
3 At present, it does not seem reasonable to consider the sequencing of the entire NAT2
gene in thousands of  individuals  and some form of  data reduction is  necessary.  The
adoption of a marker selection strategy, such as the haplotype-tagging approach, can
significantly reduce the scale and cost  of  genotyping.  The key idea is  to use linkage
disequilibrium (LD) to gain maximal information from typing a selected subset of highly
informative single-nucleotide polymorphism (SNP) markers,  referred to as “haplotype
tagging SNPs” (htSNPs) (Halldorsson et al. 2004).This approach thus requires a thorough
description of LD patterns in NAT2 in the targeted populations. Moreover, in view of the
marked population heterogeneity in NAT2 allele frequencies, it is especially important to
characterize variability in haplotype structure within and between human populations.
4 Using data collected from an extensive survey of  the literature,  this  study aimed to
characterize the worldwide patterns of LD at the NAT2 gene and to evaluate haplotype
tagging efficiency at this locus. We defined population-specific sets of htSNPs to be used
for  future association studies  and examined how well  continent-specific  htSNPs sets,
defined by grouping the population haplotypes in each continental region, perform in
populations within a same continent. The performance of a “cosmopolitan” htSNPs set
suitable for all human populations was also empirically evaluated. 
 
Materials and methods
Population samples and NAT2 molecular data
5 We selected from published reports up to July 2006 all the population samples that were
genotyped for the seven most common SNPs at NAT2 and for which genotype data was
available. These seven SNPs are the main polymorphisms occurring in human populations
at NAT2. The analysis of these seven variants has been shown to be highly predictive of
the acetylation phenotype with a prediction rate close to 100% (Mrozikiewicz et al. 1996;
Meisel et al. 1997; Gross et al. 1999; Jorge-Nebert et al. 2002; Lee et al. 2002). Among
these seven SNPs, all located in the coding exon, four result in an amino acid substitution
that leads to a significant decrease in acetylation capacity (G191A, T341C, G590A, G857A).
The  other  three  are  either  silent  mutations  (C282T,  C481T)  or  non-synonymous
substitutions that do not alter the phenotype (A803G). 
6 The collected data consisted of 3,994 individuals (7,988 chromosomes) from 28 human
populations representing major geographic regions (table I): Europe and North Africa
(13  samples),  sub-Saharan  Africa  (7),  East  Asia  (5),  Central/South  Asia  and  Central
America (3). Sample sizes range from 24 (Somali) to 844 (German) individuals, with an
average of 140 individuals per sample. A full description of each selected sample and the
corresponding references are provided elsewhere (Sabbagh et al. 2008b).
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Table I—Haplotype tagging of the NAT2 gene
Tabl. I - Marquage haplotypique du gène NAT2
 
Statistical analyses
7 From the unphased multi-locus genotypes provided by each study, we inferred NAT2
haplotypes using the Bayesian method implemented in PHASE v.2.1 (Stephens, Donnelly
2003), using the default parameter values in the Markov chain Monte Carlo simulations.
For each data set investigated, we applied the algorithm ten times with different seeds for
the random number generator,  and checked for consistency of the results across the
independent runs in order to verify that the algorithm did not converge to a local, rather
than  global,  mode  of  the  posterior  distribution.  We  chose  the  results  from the  run
displaying the best average goodness-of-fit of the estimated haplotypes to the underlying
coalescent model. Haplotypes inferred by PHASE were then used as inputs in the DnaSP
and tagSNPs programs used in subsequent analyses. 
8 Using DnaSP (Rozas et al. 2003), the r2 statistic (Hill, Robertson 1968) was computed to
estimate pairwise LD between the seven genotyped SNPs, after the exclusion, in each
population, of SNPs with minor allele frequency (MAF) < 0.05. Statistical significance of LD
between  SNP  pairs  was  assessed  using  Fisher’s  exact  tests  followed  by  Bonferroni
corrections.  Mantel  tests  to  compare r2 matrices  were performed using the program
CADM (Legendre, Lapointe 2004). Comparisons were made between populations within
each continental group. Subsequently, r2 values were recalculated for populations pooled
into geographical groups and Mantel tests were again applied. Based on the inter-marker
LD patterns observed, we selected, in each sample and each geographical region, the most
informative subset of SNPs that retain most of the haplotype information within NAT2.
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For that purpose, we used the haplotypestatistic (Stram et al. 2003), implemented in the
tagSNPs program (Stram et al. 2003), which identifies a minimal set of tag markers that
optimizes the predictability of common haplotypes (frequency > 0.05). We required the
minimum estimated haplotype value for all common haplotypes to be ≥ 0.80. To assess the
savings in genotyping offered by tagging, we defined a ‘saving index’, calculated as the
total number of polymorphic markers (with MAF > 0.0) genotyped in a sample divided by
the number of htSNPs selected. We also evaluated the tagging efficiency of each htSNPs
set by dividing the mean coefficient of determination of all  common haplotypes in a
sample (mean) by the number of htSNPs in the set.
 
Results
9 A total of 3,994 individuals from 28 worldwide samples were analyzed for their genotype
at the seven common SNPs of the NAT2 gene. The genotypic distributions at each SNP in
the  different  populations  were  not  significantly  different  from  Hardy-Weinberg
proportions (all p-values were smaller than 5% after Bonferroni correction for multiple
testing). The LD structure of NAT2 was investigated by computing the r2 measure of LD
between SNP pairs. We first tested whether the amount of LD differed between human
populations. All population samples displayed similar levels of LD within each geographic
area, except Somali who showed higher LD at NAT2 (average r2 value = 0.589) than other
sub-Saharan African samples and were, in that respect, more similar to Europeans (table
I).  The  mean  pairwise  r2 value  between  the  seven  SNPs  in  the  European  samples
(0.567 ± 0.075, including Moroccans) was significantly higher (Wilcoxon’s test, P ≤ 0.0002)
than in both East Asians (0.276 ± 0.023) and Africans (0.243 ± 0.050, without Somali). No
difference in the level  of  LD was found between East  Asian and African populations.
However,  the  proportion  of  SNP  pairs  with  r2 ≥ 0.5  was  far  smaller  in  sub-Saharan
Africans (6.7%) than in both Europeans (40%) and East Asians (33.3%). Ashkenazi Jews
exhibited the highest level of LD (average r2 value = 0.763); such an excess of LD is often
observed in founder populations that recently grew from relatively small sizes (Shifman,
Darvasi 2001). We then tested whether the structure of LD was similar among populations
by  computing  the  correlation  between r2 matrices  of  LD.  Mantel’s  tests  gave  highly
significant correlation values both between population pairs within geographic areas and
for pairs of continental regions (P < 0.0001 with 10,000 permutations).  Thus,  although
Europeans exhibited higher levels of LD at NAT2,  the pattern of LD in this gene was
similar across human populations. 
10 The number of haplotypes inferred from the unphased multi-locus genotype data in each
sample is displayed in table I, as well as the haplotype diversity. Sub-Saharan African
populations displayed greater haplotype diversity than either Europeans or Asians.  A
larger number of haplotypes of similar frequencies occur indeed in these populations,
generating a huge number of distinct genotypes. By contrast,  in populations of Asian
origin,  only  a  few  major  haplotypes  were  found,  namely  NAT2*4,  NAT2*6A and
NAT2*7B. The mean haplotype diversity was estimated to be 0.79 ± 0.06 in Africans and
0.59 ± 0.11 in East Asians. Europeans displayed an intermediate value of 0.69 ± 0.04.
11 For each of the 28 worldwide samples, we defined sets of htSNPs that captured most of
the  haplotype  diversity  of  the  NAT2 coding  region  ( table  I).  We  used  the
haplotypecriterion (Stram et al. 2003), which reflects the degree to which a given htSNPs
set explains the variability in the haplotypes it is chosen to tag. Aof 0.80 was selected as a
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threshold for tag selection and performance measurement.  In all  population samples,
except sub-Saharan Africans, only a few common haplotypes explained the vast majority
of all chromosomes (~90% and more), and only two to three htSNPs were sufficient to
adequately characterize the common variation: the mean coefficient of determination
(mean) of all common haplotypes was near or above 0.90 in each sample. The best tagging
efficiency was observed in East Asians who exhibited the lowest haplotype diversity at
NAT2. In contrast, in sub-Saharan Africans, where greater haplotype diversity and lower
levels of LD were observed, no reduction in the genotyping requirement was possible as
SNPs were poor markers of each other in these samples (except in Somali where the
number of  SNPs could be reduced from seven to four).  We next designed continent-
specific sets of htSNPs, by grouping the population haplotypes in each continent, as well
as a worldwide set of htSNPs, by pooling all 28 samples into a single population, and using
three  different  thresholds  offor  tag  selection  (0.80,  0.85,  and  0.90)  (table  II).  We
evaluated the  performance  of  these  htSNPs  sets  in  individual  samples  by  examining
whether the minimum estimated haplotype was ≥ 0.80 or not in the tested sample with
the considered htSNPs set. When a threshold of 0.80 was used for htSNPs selection, the
continent-specific  and  worldwide  htSNPs  sets  did  not  perform  well  in  ~40%  of  the
samples, thus demonstrating low transferability. In Europe/North Africa and East Asia, a
more stringent threshold of 0.90 was needed to identify htSNPs sets that consistently
perform well in all  samples within each geographic area. In sub-Saharan Africans, no
reduction in the number of SNPs was possible whatever the threshold used. A four-htSNP
set (C282T, C481T, G590A, A803G), selected using either a 0.85 or a 0.90 threshold from the
pooled worldwide samples, performed successfully in all the 21 non-African samples but
not at all in sub-Saharan Africans.
 
Table II—Transferability of continent-specific and worldwide htSNPs sets among human
populations.
Tabl. II - Transférabilité des htSNP dans les populations humaines, par continent et pour l’ensemble
des continents.
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Discussion
12 This study provided a thorough description of the haplotype diversity and LD structure of
NAT2 at a worldwide level. It enabled the definition of population-specific htSNPs sets
which should be extremely useful for future association studies.
13 Our analyses revealed very similar patterns of LD among human populations at the NAT2
locus,  although disparities  in  the  level  of  LD  appeared  among  the  main  continental
groups. Even within a small gene like NAT2,  the SNP markers appeared to be poorly
correlated in sub-Saharan Africans and the whole set of SNPs initially genotyped in these
populations was needed to accurately represent the common variation at this locus (
table I , II).  There were therefore almost no gains from haplotype tagging in these
populations. An exception is the Somali sample which displayed a higher level of LD at
NAT2 compared to the other sub-Saharan African populations examined and for which a
greater reduction in the number of SNPs required to accurately represent the NAT2
common variation was observed. Since the full NAT2 gene diversity has not yet been
investigated in other East African populations, it is not possible to conclude whether this
population is peculiar with respect to this genetic system, whether it resembles other
East African populations, or whether these observations result from the small size of the
Somali sample (N = 24) which may not be representative of the NAT2 genetic variation in
the Somali population. In contrast, only 2 to 3 SNPs were sufficient to capture most of the
variation in the European and Asian samples. If a reduction from 7 to 2-3 SNPs to be typed
may  seem  negligible  with  the  advent  of  high-throughput  technologies  for  SNP
genotyping, the savings in cost and time are no more trivial if such a 2- to 3- fold saving is
achieved  in  each  of  the  hundreds  or  thousands  of  genes  to  be  typed  in  large-scale
association studies, that adopt either a whole-genome or candidate-gene approach.
14 htSNPs sets appeared to be portable among populations from a same continent, provided
that the continent-specific htSNPs sets were selected with a stringent criterion (minimum
haplotype  ≥ 0.90). A “cosmopolitan” htSNPs set suitable for all human populations could
not be identified for the NAT2 gene, unless considering all the seven common SNPs of
this  gene.  However,  it  was  possible  to  identify  a  single  four-htSNP  set  that  worked
adequately in multiple human populations of non-African origin. This set was of the same
size or just a little bit larger than the European and East-Asian continent-specific htSNPs
sets (each composed of four and three SNPs, respectively). Additional studies are needed
to determine whether this four-htSNP set still performs well in larger numbers of non-
African populations. The use of a single htSNPs set in multiple populations would ensure
comparability for replication efforts within complex traits and would also allow direct
comparison of the role of the same variants as risk factors for different conditions (Need,
Goldstein 2006). However, if the number of SNPs to be genotyped has to be significantly
reduced, one should better apply SNP selection procedures separately in each individual
population.
15 A recent study has empirically evaluated the ability of tagging markers selected in NAT2
to predict the individual acetylator status (Sabbagh et al. 2008a): the functional variation
was shown to be adequately represented by the selected tagging markers, these latter
providing  a  classification  accuracy  for  the  individual  acetylator status  close  to  the
maximal 100% value observed with the entire set of common polymorphisms in this gene.
Therefore, the tagging approach appears as a valuable tool for pharmacogenetic studies
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testing NAT2 genetic variation for association with a given clinical trait. Even if tagging
will  probably  be  replaced  later  on  by  high-throughput  sequencing  which  enable
comprehensive  studies  of  human  genetic  variation,  indirect  association  studies  via
haplotype tagging appear as an efficient and economical approach at present and should
remain so for the near future, especially when screening a large number of candidate
genes. 
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RÉSUMÉS
Le  polymorphisme  génétique  du  gène  NAT2  est  responsable  de  fortes  différences
interindividuelles  de  l’activité  d’acétylation  de  l’enzyme  N-acetyltransférase  2  (NAT2).  Cette
enzyme  joue  un  rôle  fondamental  dans  le  métabolisme  de  nombreux  xénobiotiques  et
médicaments utilisés en clinique.  Jusqu’à présent,  la plupart des études d’association qui ont
tenté de relier les phénotypes d’acétylation du gène NAT2 à plusieurs maladies complexes chez
l’homme  ont  conduit  à  des  résultats  contradictoires,  essentiellement  en  raison  des  faibles
connaissances sur la variation géographique des profils de déséquilibre de liaison au locus NAT2.
C’est pourquoi nous avons entrepris une étude exhaustive de la littérature relatant la diversité
mondiale haplotypique du gène NAT2 et décrivant les déséquilibres de liaison entre différents
SNP (Single Nucleotide Polymorphism) de ce gène. Notre échantillon comprend 28 populations
(incluant 3994 individus) réparties sur quatre continents (Afrique, Europe, Asie, Amérique). Pour
chacune d’elles, nous avons estimé l’efficacité du marquage haplotypique (tagging) et défini le
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sous-ensemble de SNP (htSNP) qui s’avère juste nécessaire pour réaliser efficacement des études
d’association. Ce marquage haplotypique permet de réduire d’un facteur 2 à 3 fois le nombre de
SNP à étudier, du moins pour les populations d’Europe et d’Asie de l’Est. En revanche, la diversité
haplotypique  en  Afrique  est  telle  qu’aucune  réduction  n’est  possible  pour  ce  continent.  Les
marqueurs htSNP sélectionnés dans une population restent performants pour le continent dans
lequel  elle  se  situe,  à  la  condition  que  les  htSNP  aient  été  sélectionnés  avec  un  critère
suffisamment  « stringent ».  Pour  ce  gène  NAT2,  il  n’est  pas  possible  d’identifier  un  unique
ensemble  de  htSNP qui  serait  « universel »  et  efficace  pour  toutes  les  populations ;  mais  un
ensemble  réduit  à  seulement  quatre  htSNP  reste  parfaitement efficace  dans  le  cas  des
populations non africaines.
Genetic  polymorphism  in  the  NAT2  gene  is  responsible  for  pronounced  interindividual
differences in the acetylation activity of the N-acetyltransferase 2 (NAT2) enzyme, which plays a
crucial role in the metabolism of many clinically useful drugs and exogenous chemicals. Up to
now, most association studies that have attempted to relate the acetylation phenotype in NAT2
to  a  variety  of  complex  human  disorders  have  led  to  contradictory  results  in  different
populations. Some of these inconsistencies may result from a poor knowledge of linkage patterns
at NAT2 and their geographic variation. Using data from an extensive survey of the literature, we
investigated the worldwide haplotype diversity and linkage disequilibrium structure of NAT2.
For 28 population samples (including 3,994 individuals) from four continental regions (Africa,
Europe,  Asia,  America),  we  evaluated  haplotype  tagging  efficiency  at  NAT2  and  defined
population-specific sets of  haplotype tagging SNPs (htSNPs) to be used for future association
studies.  Tagging common haplotypes yielded 2- to 3-fold savings in European and East Asian
samples,  while  no  gains  from  tagging  were  observed  in  samples  of  African  ancestry,  which
displayed  high  haplotype  diversity  at  NAT2.  htSNPs  sets  appeared  to  be  portable  among
populations  from  a  same  continent,  provided  that  the  continent-specific  htSNPs  sets  were
selected  with  a  stringent  criterion.  A  “cosmopolitan”  htSNPs  set  suitable  for  all  human
populations could not be identified for the NAT2 gene, but a single four-htSNP set proved to
perform successfully in all the non-African populations investigated.
INDEX
Mots-clés : déséquilibre de liaison, études d’association, génétique des populations, marquage
haplotypique, NAT2
Keywords : association studies, haplotype tagging, linkage disequilibrium, population genetics
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